NIP
AXSM icon

Nicholas Investment Partners’s Axsome Therapeutics AXSM Stock Holding History

Nicholas Investment Partners’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.8M Sell
81,478
-10,086
-11% -$1.74M 0.99% 29
2025
Q4 		$16.7M Buy
91,564
+42,907
+88% +$5.99M 1.22% 12
2025
Q3 		$5.91M Buy
48,657
+6,503
+15% +$733K 0.45% 74
2025
Q2 		$4.4M Sell
42,154
-1,418
-3% -$150K 0.39% 103
2025
Q1 		$5.08M Buy
43,572
+33,437
+330% +$3.81M 0.52% 75
2024
Q4 		$858K Hold
10,135
– – 0.08% 189
2024
Q3 		$911K Buy
+10,135
New +$885K 0.08% 189
2024
Q2 		– Sell
-36,816
Closed -$2.94M – 199
2024
Q1 		$2.94M Sell
36,816
-45,829
-55% -$3.85M 0.3% 122
2023
Q4 		$6.58M Sell
82,645
-312,335
-79% -$20.9M 0.77% 38
2023
Q3 		$27.6M Buy
394,980
+96
+0% +$7.18K 2.06% 11
2023
Q2 		$28.4M Buy
394,884
+54,454
+16% +$4.02M 1.94% 13
2023
Q1 		$21M Buy
340,430
+140,176
+70% +$9.21M 1.6% 21
2022
Q4 		$15.4M Buy
+200,254
New +$12M 1.35% 22
2021
Q2 		– Sell
-138,571
Closed -$7.85M – 201
2021
Q1 		$7.85M Sell
138,571
-68,881
-33% -$4.85M 0.55% 60
2020
Q4 		$16.9M Buy
207,452
+19,696
+10% +$1.47M 1.31% 23
2020
Q3 		$13.4M Buy
187,756
+165,355
+738% +$12.9M 1.45% 22
2020
Q2 		$1.84M Sell
22,401
-34,400
-61% -$2.65M 0.37% 103
2020
Q1 		$3.34M Buy
56,801
+44,358
+356% +$3.61M 0.65% 61
2019
Q4 		$1.29M Buy
+12,443
New +$503K 0.13% 161

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nicholas Investment Partners's AXSM Position: Q1 2026 in Review

Nicholas Investment Partners reduced its Axsome Therapeutics (AXSM) stake by 11% in Q1 2026, selling an estimated $1.74M and leaving 81,478 shares worth $13.8M. The position accounts for 0.99% of the portfolio, ranked #29.

Nicholas Investment Partners first reported a position in AXSM in Q4 2019 and has held it in 19 quarters since. The position peaked at $28.4M in Q2 2023. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Nicholas Investment Partners held 81,478 shares of Axsome Therapeutics worth $13.8M as of Q1 2026.
  • Nicholas Investment Partners sold 10,086 Axsome Therapeutics shares in Q1 2026, an estimated $1.74M.
  • Axsome Therapeutics made up 0.99% of Nicholas Investment Partners's portfolio in Q1 2026, its #29 holding.
  • Nicholas Investment Partners first reported a position in Axsome Therapeutics in Q4 2019 and has held it in 19 quarters since.
  • Nicholas Investment Partners's Axsome Therapeutics position peaked at $28.4M in Q2 2023.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Nicholas Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.